JordanTShinMD

Adult Congenital Heart Disease, Heart Failure & Transplantation, Non-Invasive Cardiology

Instructor, Medicine, Massachusetts General Hospital, Harvard Medical School

Dr. Shin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Fruit St
Yaw 5 Cardiac Unit Associates
Boston, MA 02114
Phone+1 617-724-6750

Fax+1 617-724-6767

PubMed

34 citations
Pharmacological HIF2α inhibition improves VHL disease–associated phenotypes in zebrafish model
Ana M. Metelo, Haley R. Noonan, Xiang Li, Youngnam N. Jin, Rania Baker
The Journal of Clinical Investigation. 2015-05-01
99 citations
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase
Yan Liu, Aarti Asnani, Lin Zou, Victoria L. Bentley, Min Yu
Science Translational Medicine. 2014-12-10
44 citations
Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development
Jason R Becker, Sneha Chatterjee, Tamara Y. Robinson, Jeffrey S. Bennett, Daniela Panáková
Development. 2014-01-15

Targeting Mitochondrial Enzyme May Reduce Chemotherapy Drug’s Cardiac Side EffectsDecember 10th, 2014

The Role Of BMPR2 In Blood Vesel Development And Patterning In VivoNational Heart, Lung, And Blood Institute2008–2012